Vital Chemtech Ltd

Vital Chemtech Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Vital Chemtech Ltd

₹ 76.8 0.46%
11 Dec 11:49 a.m.
vitalgroup.co.in NSE - SME: VITAL
About

Incorporated in 2014, Vital Chemtech Ltd manufactures and supplies phosphorous based chemicals[1]

Key Points

Business Overview:[1][2]
VCL is a part of Vital Group which is a multi-product organization involved in Manufacturing, Contract Manufacturing and Exports of Chemicals. Company does manufacturing and supplying of Phosphorus Derivatives Products and Phosphorus base chemicals. It also does trading of its raw Material and is in the process of obtaining approval of Phosphorus Pentasulfide (P2S5)

Website NSE - SM
  • Market Cap ₹ 184 Cr.
  • Current Price ₹ 76.8
  • High / Low ₹ 115 / 67.0
  • Stock P/E
  • Book Value ₹ 38.1
  • Dividend Yield 0.65 %
  • ROCE 0.34 %
  • ROE -0.74 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • Earnings include an other income of Rs.2.98 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Edit Columns
Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024
52 58 61 56 50 49 66
44 46 51 51 48 50 61
Operating Profit 8 12 9 6 2 -2 5
OPM % 16% 20% 15% 10% 4% -3% 7%
0 0 0 -0 2 2 1
Interest 0 0 0 1 0 1 1
Depreciation 1 1 1 1 1 2 2
Profit before tax 7 11 8 4 2 -2 3
Tax % 34% 26% 23% 45% 14% 26% 29%
5 8 6 2 2 -3 2
EPS in Rs 11.75 3.46 0.82 0.78 -1.32 0.96
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 TTM
58 117 98 114
46 102 98 111
Operating Profit 12 15 0 3
OPM % 20% 13% 0% 3%
0 0 3 3
Interest 0 1 1 2
Depreciation 1 2 3 4
Profit before tax 11 11 -0 1
Tax % 26% 30% 269%
8 8 -1 -1
EPS in Rs 11.75 3.36 -0.54 -0.36
Dividend Payout % 0% 15% -92%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 8%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -122%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -10%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: -1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 7 24 24 24
Reserves 8 66 60 67
36 29 26 25
30 19 27 38
Total Liabilities 81 138 137 155
17 25 43 56
CWIP 0 0 0 0
Investments 3 15 35 25
61 98 60 74
Total Assets 81 138 137 155

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
-13 -8 14
1 -26 -35
18 58 -9
Net Cash Flow 6 24 -30

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024
Debtor Days 264 120 146
Inventory Days 87 57 61
Days Payable 265 65 123
Cash Conversion Cycle 87 112 84
Working Capital Days 153 136 113
ROCE % 15% 0%

Shareholding Pattern

Numbers in percentages

Nov 2022Mar 2023Sep 2023Mar 2024Sep 2024
73.28% 73.43% 73.43% 73.43% 73.43%
6.53% 3.62% 0.78% 0.56% 0.16%
4.12% 1.81% 0.96% 0.33% 0.25%
16.07% 21.14% 24.83% 25.68% 26.16%
No. of Shareholders 2,2841,8792,2762,3202,432

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports